PCVX SG&A Expense Growth

Vaxcyte Inc · SG&A Expense Growth

PCVX logo

PCVX SG&A Expense Growth

Latest reported39.25%
PCVX FY SG&A Growth (YoY) (0.00% → 39.25%)
High-resolution chart · PNG

PCVX sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Vaxcyte Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
39.2532%
53.0511%
52.4743%
57.6072%
72.8648%
99.7812%
35.7461%
6.7353%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.